Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2014 (2014), Article ID 731581, 4 pages
http://dx.doi.org/10.1155/2014/731581
Case Report

Importance of HER2 Work-Up and Treatment Even in Patients with Poor Performance Status: A Case Report

1Department of Medical Oncology, School of Medicine, Gaziantep University, Kilis Yolu Uzeri, 27310 Gaziantep, Turkey
2Depatment of Internal Medicine, Harran University School of Medicine, Sanliurfa, Turkey

Received 21 February 2014; Accepted 31 March 2014; Published 13 April 2014

Academic Editor: Sercan Aksoy

Copyright © 2014 Ali Suner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, J. Ma, Z. Zou, and A. Jemal, “Cancer statistics,” CA: Cancer Journal for Clinicians, vol. 64, no. 1, pp. 9–29, 2014. View at Publisher · View at Google Scholar
  2. A. Ferro, B. Peleteiro, M. Malvezzi et al., “Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype,” European Journal of Cancer, vol. 50, no. 7, pp. 1330–1344, 2014. View at Publisher · View at Google Scholar
  3. T. Gotoda, A. Yanagisawa, M. Sasako et al., “Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers,” Gastric Cancer, vol. 3, no. 4, pp. 219–225, 2000. View at Google Scholar · View at Scopus
  4. D. Cunningham, W. H. Allum, S. P. Stenning et al., “Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer,” The New England Journal of Medicine, vol. 355, no. 1, pp. 11–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. S. C. Cunningham, F. Kamangar, M. P. Kim et al., “Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution,” Journal of Gastrointestinal Surgery, vol. 9, no. 5, pp. 718–725, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. A. D. Wagner, W. Grothe, J. Haerting, G. Kleber, A. Grothey, and W. E. Fleig, “Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data,” Journal of Clinical Oncology, vol. 24, no. 18, pp. 2903–2909, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Sasako, M. Inoue, J.-T. Lin, C. Khor, H.-K. Yang, and A. Ohtsu, “Gastric cancer working group report,” Japanese Journal of Clinical Oncology, vol. 40, supplement 1, pp. i28–i37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Gravalos and A. Jimeno, “HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target,” Annals of Oncology, vol. 19, no. 9, pp. 1523–1529, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-J. Bang, E. van Cutsem, A. Feyereislova et al., “Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial,” The Lancet, vol. 376, no. 9742, pp. 687–697, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Chau, A. R. Norman, D. Cunningham, J. S. Waters, J. Oates, and P. J. Ross, “Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer—pooled analysis from three multicenter, randomized, controlled trials using individual patient data,” Journal of Clinical Oncology, vol. 22, no. 12, pp. 2395–2403, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Meza-Junco and M. B. Sawyer, “Metastatic gastric cancer—focus on targeted therapies,” Biologics, vol. 6, pp. 137–146, 2012. View at Google Scholar
  12. W. Koizumi, H. Narahara, T. Hara et al., “S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial,” The Lancet Oncology, vol. 9, no. 3, pp. 215–221, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Yoshikawa, K. Omura, O. Kobayashi et al., “A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study),” European Journal of Surgical Oncology, vol. 36, no. 6, pp. 546–551, 2010. View at Publisher · View at Google Scholar · View at Scopus